Guardant Health, Inc. (GH): Price and Financial Metrics

Guardant Health, Inc. (GH): $32.65

1.67 (+5.39%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

C

GH Price/Volume Stats

Current price $32.65 52-week high $37.04
Prev. close $30.98 52-week low $15.81
Day low $30.83 Volume 2,170,300
Day high $33.45 Avg. volume 2,072,090
50-day MA $24.22 Dividend yield N/A
200-day MA $24.47 Market Cap 4.03B

GH Stock Price Chart Interactive Chart >


Guardant Health, Inc. (GH) Company Bio


Guardant Health, Inc., a precision oncology company, provides non-invasive cancer diagnostics. It offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that measures various cancer-related genes from circulating tumor DNA (ctDNA); and GuardantOMNI, a broader panel measuring various genes from ctDNA. The company also provides LUNAR-1 for recurrence detection in cancer survivors; and LUNAR-2 for early detection of cancer in higher risk individuals. Guardant Health, Inc. was founded in 2011 and is based in Redwood City, California.


GH Latest News Stream


Event/Time News Detail
Loading, please wait...

GH Latest Social Stream


Loading social stream, please wait...

View Full GH Social Stream

GH Price Returns

1-mo 61.63%
3-mo 12.51%
6-mo N/A
1-year 34.97%
3-year -69.56%
5-year -59.25%
YTD 20.70%
2023 -0.55%
2022 -72.81%
2021 -22.39%
2020 64.93%
2019 107.87%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!